Mira Jung
Fundador en SHUTTLE PHARMACEUTICALS HOLDINGS, INC. .
Fortuna: 568 907 $ al 31/05/2024
Perfil
Mira Jung is the founder of Shuttle Pharmaceuticals, Inc. (founded in 2012) and Shuttle Pharmaceuticals Holdings, Inc. (founded in 2012) where she holds the title of Scientific Director and Chief Scientific Officer-Biology respectively.
Dr. Jung also worked as a Professor at Georgetown University School of Medicine.
She obtained her graduate and doctorate degrees from the University of Kansas.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/03/2024 | 1 071 388 ( 6.38% ) | 568 907 $ | 31/05/2024 |
Cargos activos de Mira Jung
| Empresas | Cargo | Inicio |
|---|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Fundador | 18/12/2012 |
Shuttle Pharmaceuticals, Inc.
 Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Fundador | 01/12/2012 |
Antiguos cargos conocidos de Mira Jung.
| Empresas | Cargo | Fin |
|---|---|---|
| Georgetown University School of Medicine | Corporate Officer/Principal | - |
Formación de Mira Jung.
| University of Kansas | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Mira Jung
